The adverse effect of an unplanned surgical excision of foot soft tissue sarcoma

Table 1 Patients' data.

Case	Age	Sex	Diagnosis	LC	CC	Stage	FNCLCC grade	Size	FSM	LP	Chem	RT	Follow-up (months)	Prog	Group
1	25	M	RMS	4	Uncertain	II-B	3	S	amp	No	No	Yes	6	DOD	UT
2	46	F	SS	5	Mass	II-B	3	S	amp	No	Yes	No	7	DOD	UT
3	50	M	LPS	3	Mass	I-B	1	B	wide	Yes	No	No	24	CDF	PT
4	2	F	RMS	4	Swelling	III-B	3	S	no op	Yes	Yes	Yes	11	DOD	PT
5	33	M	CCS	5	Mass	II-B	2	B	amp	No	No	No	128	CDF	PT
6	41	M	SS	4	Mass	I-B	2	S	ad	Yes	No	No	89	CDF	UT
7	10	M	FS	3	Mass	II-B	2	B	wide	Yes	Yes	No	170	CDF	PT
8	67	M	CSSP	4	Uncertain	II-B	2	B	amp	No	No	No	7	DOC	PT
9	42	M	LMS	4	Pain, mass	II-B	2	B	amp	No	Yes	No	38	DOD	PT
10	39	F	SS	4	Tenderness	II-B	2	B	ad	Yes	Yes	No	92	AWD	UT
11	47	M	SS	4	Mass	II-B	3	B	amp	No	No	No	110	CDF	PT
12	19	F	CCS	2	Tenderness	II-B	2	S	ad	Yes	No	Yes	84	NED	UT
13	66	M	ESMCS	4	Uncertain	I-B	1	B	wide	Yes	No	Yes	12	AWD	PT
14	14	M	DFSP	3	Mass	II-A	2	B	wide	Yes	No	No	13	CDF	PT

Patients are in chronological order. LC, location; CC, chief complaint; FNCLCC grade, Fédération Nationale des Centres de Lutte Contre le Cancer Grading System; FSM, final surgical margin; LP, limb preservation; Chem, chemotherapy; RT, radiation therapy; Prog, Prognosis. CCS, Clear cell sarcoma; CSSP, chondrosarcoma of soft part; DFSP, dermatofibrosarcoma protuberance; ESMCS, extraskeletal myxoid chondrosarcoma; FS, fibrosarcoma; LMS, leiomyosarcoma; LPS, liposarocoma; RMS, rhabdomyosarcoma; SS, synovial sarcoma. Tumor size: S, < 3 cm; B, ≥3 cm; amp, amputation; wide, wide resection; no op, no operation; ad, additional wider resection; AWD, alive with disease; CDF, complete disease free; NED, no evidence of disease; DOD, died of disease; DOC, died of other causes. PT, planned excision; UT, unplanned excision.

ISSN: 1477-7819